Evidence map›Paper›PMID 30144425›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2018

Mitochondrial regulation of diabetic vascular disease: an emerging opportunity.

Michael E Widlansky, R Blake Hill

Abstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Endothelial Metabolic Reprogramming Links Diabetes to Atherosclerosis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Impaired microvascular insulin-dependent dilation in women with a history of gestational diabetes.American journal of physiology. Heart and circulatory physiology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael E WidlanskyDepartment of Medicine, Division of Cardiovascular Medicine and Department of Pharmacology, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mwidlans@mcw.edu.
R Blake HillDepartment of Biochemisty, Medical College of Wisconsin, Milwaukee, Wisconsin.
Medical College of Wisconsin · US

Funding

Structural Biology of Mitochondrial FissionR01GM067180 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI HILL, R BLAKE · 2004 to 2022
$6.0M
Endothelial function in human diabetes: role of mitochondrial fission proteinsR01HL128240 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI WIDLANSKY, MICHAEL E · 2016 to 2020
$2.9M
MicroRNA-29b and Endothelial FunctionR01HL125409 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU, WIDLANSKY, MICHAEL E · 2015 to 2018
$2.0M
NHLBI NIH HHS R01 HL125409NHLBI NIH HHS R01 HL128240NIGMS NIH HHS R01 GM067180
6 · The paper itself

Abstract

Diabetes-related vascular complication rates remain unacceptably high despite guideline-based medical therapies that are significantly more effective in individuals without diabetes. This critical gap represents an opportunity for researchers and clinicians to collaborate on targeting mechanisms and pathways that specifically contribute to vascular pathology in patients with diabetes mellitus. Dysfunctional mitochondria producing excessive mitochondrial reactive oxygen species (mtROS) play a proximal cell-signaling role in the development of vascular endothelial dysfunction in the setting of diabetes. Targeting the mechanisms of production of mtROS or mtROS themselves represents an attractive method to reduce the prevalence and severity of diabetic vascular disease. This review focuses on the role of mitochondria in the development of diabetic vascular disease and current developments in methods to improve mitochondrial health to improve vascular outcomes in patients with DM.

Indexed as

AnimalsDiabetic AngiopathiesEndothelium, VascularHumansMitochondriaMitochondrial ProteinsMitophagyReactive Oxygen SpeciesMitochondrial ProteinsReactive Oxygen SpeciesAbbreviations: CuZn SODcopper-zinc superoxide dismutasediabetes mellitusDMDrp1dynamin-related protein 1electron transport chainETCFFAfree fatty acidshuman umbilical vein endothelial cellsHUVECsmanganese superoxide dismutaseMdivi-1Mfn1/2mitochondrial division inhibitor 1mitochondrial membrane potentialmitochondrial permeability transition poremitochondrial reactive oxygen speciesmitofusin 1/2MnSODmPTPmtROSnicotinamide mononucleotidenicotinamide ribosidenitric oxideNMNNONROPA-1optic atrophy protein 1SIRT1sirtuin-1SSSzeto-SchillerUCP2uncoupling protein 2Δψ(m)

Identifiers

PMID30144425
PMCPMC6218302
OpenAlexW2885334584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.